Related Experiment Video
Updated: Aug 1, 2026

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
Published on: October 5, 2015
Combined ganciclovir and foscarnet in pediatric cytomegalovirus retinitis
S M Sastry1, C H Epps, R C Walton
1Division of Ophthalmology, Howard University Hospital, Washington, DC, USA.
Insights
Cytomegalovirus retinitis causes blindness in children with AIDS. Early combined therapy with foscarnet and ganciclovir effectively halted retinitis progression in a pediatric case unresponsive to ganciclovir alone.
Area of Science:
- Ophthalmology
- Pediatrics
- Infectious Diseases
Background:
- Cytomegalovirus (CMV) retinitis is a significant cause of vision loss in individuals with acquired immunodeficiency syndrome (AIDS).
- Therapeutic strategies for CMV retinitis are well-established in adults, but less documented in pediatric populations.
- CMV retinitis poses a particular challenge in immunocompromised children due to potential long-term visual impairment.
Observation:
- A case report details the clinical course of a 3-year-old child diagnosed with cytomegalovirus retinitis.
- The child initially received intravenous ganciclovir monotherapy, which proved ineffective in controlling the retinitis.
- Progression of the ocular inflammation was observed despite the initial treatment regimen.
Findings:
- Early introduction of combination therapy, utilizing both foscarnet and ganciclovir, was implemented.
- This combined treatment approach successfully halted the progression of CMV retinitis in the pediatric patient.
- The case underscores the aggressive nature of CMV retinitis in children.
Implications:
- The findings suggest that early combined antiviral therapy may be a crucial consideration for managing pediatric CMV retinitis.
- This contrasts with typical adult treatment protocols and highlights potential differences in disease management between age groups.
- Further research into pediatric-specific treatment guidelines for CMV retinitis is warranted to optimize visual outcomes.
Abstract:
Cytomegalovirus retinitis is the leading cause of blindness in adults and children with acquired immunodeficiency syndrome (AIDS). Although clinical trials on therapy exist for adults, management of cytomegalovirus retinitis in children is not as well-documented. This report describes the clinical course of a 3-year-old child with cytomegalovirus retinitis. After initial failure with single-agent ganciclovir intravenous treatment, early institution of combined treatment with foscarnet and ganciclovir halted progression of the retinitis. This case report highlights the aggressive nature of cytomegalovirus retinitis in children and the consideration of early combined therapy compared to adult patients.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Cytomegalovirus Disease
Cryptococcal Meningitis
Antiviral Nucleoside Inhibitors
Diabetic Retinopathy

